Omeros Corporation [NASDAQ: OMER] plunged by -$1.11 during the normal trading session on Tuesday and reaching a high of $11.86 during the day while it closed the day at $10.84. The company report on August 31, 2020 that Omeros’ Investigational New Drug Application for OMS906 Cleared by FDA.
— Paroxysmal Nocturnal Hemoglobinuria Slated as Initial Indication –.
Omeros Corporation today announced that its Investigational New Drug Application (IND) to begin clinical trials with OMS906 has been cleared by the U.S. Food and Drug Administration (FDA). OMS906 is the company’s lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-3 (MASP-3), the key activator of the complement system’s alternative pathway.
Omeros Corporation stock has also loss -8.06% of its value over the past 7 days. However, OMER stock has declined by -27.49% in the 3 months of the year. Over the past six months meanwhile, it has lost -45.03% and lost -23.07% year-on date.
The market cap for OMER stock reached $646.93 million, with 54.51 million shares outstanding and 48.25 million shares in the current float. Compared to the average trading volume of 1.13M shares, OMER reached a trading volume of 2120912 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Omeros Corporation [OMER]:
H.C. Wainwright have made an estimate for Omeros Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 21, 2020. While these analysts kept the previous recommendation, Maxim Group dropped their target price from $25 to $20. The new note on the price target was released on August 14, 2020, representing the official price target for Omeros Corporation stock. Previously, the target price had yet another raise to $26, while Cantor Fitzgerald analysts kept a Overweight rating on OMER stock.
The Average True Range (ATR) for Omeros Corporation is set at 1.18, with the Price to Sales ratio for OMER stock in the period of the last 12 months amounting to 6.45.
OMER stock trade performance evaluation
Omeros Corporation [OMER] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.06. With this latest performance, OMER shares dropped by -15.31% in over the last four-week period, additionally sinking by -45.03% over the last 6 months – not to mention a drop of -41.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OMER stock in for the last two-week period is set at 36.60, with the RSI for the last a single of trading hit 31.93, and the three-weeks RSI is set at 39.52 for Omeros Corporation [OMER]. The present Moving Average for the last 50 days of trading for this stock 13.86, while it was recorded at 11.71 for the last single week of trading, and 14.03 for the last 200 days.
Omeros Corporation [OMER]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Omeros Corporation [OMER] shares currently have an operating margin of -56.69 and a Gross Margin at +97.63. Omeros Corporation’s Net Margin is presently recorded at -75.57.
Return on Total Capital for OMER is now -93.00, given the latest momentum, and Return on Invested Capital for the company is -128.09. Additionally, OMER Total Debt to Total Capital is recorded at 228.24, with Total Debt to Total Assets ending up at 141.66.
Reflecting on the efficiency of the workforce at the company, Omeros Corporation [OMER] managed to generate an average of -$327,465 per employee. Receivables Turnover for the company is 3.86 with a Total Asset Turnover recorded at a value of 0.96.Omeros Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.00.
Earnings per share (EPS) analysis for Omeros Corporation [OMER] stock
With the latest financial reports released by the company, Omeros Corporation posted -0.33/share EPS, while the average EPS was predicted by analysts to be reported at -0.41/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 19.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OMER.
Omeros Corporation [OMER]: Insider Ownership positions
There are presently around $345 million, or 52.50% of OMER stock, in the hands of institutional investors. The top three institutional holders of OMER stocks are: BLACKROCK INC. with ownership of 4,478,599, which is approximately 6.005% of the company’s market cap and around 0.20% of the total institutional ownership; INGALLS & SNYDER LLC, holding 4,437,568 shares of the stock with an approximate value of $48.1 million in OMER stocks shares; and CONSONANCE CAPITAL MANAGEMENT LP, currently with $45.2 million in OMER stock with ownership of nearly -6.92% of the company’s market capitalization.
Positions in Omeros Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 67 institutional holders increased their position in Omeros Corporation [NASDAQ:OMER] by around 1,886,681 shares. Additionally, 55 investors decreased positions by around 1,420,152 shares, while 24 investors held positions by with 28,504,474 shares. The mentioned changes placed institutional holdings at 31,811,307 shares, according to the latest SEC report filing. OMER stock had 19 new institutional investments in for a total of 303,528 shares, while 23 institutional investors sold positions of 644,846 shares during the same period.